Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adenovirus as an integrating vector.

K Mitani1, S Kubo

  • 1Department of Microbiology, Immunology & Molecular Genetics, UCLA School of Medicine, Los Angeles, CA 90095-1747, USA. Mitani@ucla.edu

Current Gene Therapy
|July 12, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oral management with polaprezinc solution reduces adverse events in haematopoietic stem cell transplantation patients.

International journal of oral and maxillofacial surgery·2020
Same author

Successful glycemic control with three times a week degludec injection by medical staff for an elderly hemodialysis patient with type 2 diabetes.

Diabetology international·2019
Same author

Easy Preparation Method for 2-Thioxopyrrolidine Derivatives Including 3-Hydroxy- methylene-2-thioxopyrrolidine, an Antimicrobial Degradation Product of Radish Pungent Principle, via (E,Z)-4-Ylethoxy-3-butenyl Isothiocyanate.

Bioscience, biotechnology, and biochemistry·2016
Same author

High-dose chemotherapy followed by autologous stem cell transplantation for relapsed/refractory primary mediastinal large B-cell lymphoma.

Blood cancer journal·2015
Same author

BTK gene targeting by homologous recombination using a helper-dependent adenovirus/adeno-associated virus hybrid vector.

Gene therapy·2015
Same author

Size distribution of total and water-soluble fractions of particle-bound elements-assessment of possible risks via inhalation.

Environmental science and pollution research international·2015

Adenoviral vectors are efficient for gene delivery but lack permanent integration. Hybrid vectors combining adenovirus with integrating elements show promise for stable, long-term gene therapy.

Area of Science:

  • Gene Therapy
  • Molecular Biology
  • Virology

Background:

  • Recombinant adenoviral vectors are highly efficient gene delivery systems in vivo.
  • Current adenoviral vectors do not achieve permanent gene expression due to lack of integration.
  • Cellular immunity against adenoviral proteins limits long-term gene expression.

Purpose of the Study:

  • To explore strategies for achieving stable, long-term gene expression using adenoviral vectors.
  • To investigate methods for improving the integration frequency of adenoviral vectors into host genomes.
  • To evaluate the potential of hybrid vector systems for enhanced gene therapy applications.

Main Methods:

  • Development of multiply attenuated or gutless adenoviral vectors to overcome cellular immunity.

Related Experiment Videos

  • Investigation of replication-incompetent adenoviral vector integration into host chromosomes.
  • Construction and testing of hybrid vectors combining adenoviral delivery with retroviral, adeno-associated virus, or transposon integration machinery.

    • Main Results:

    • Adenoviral vectors can achieve long-term gene expression in animal models by overcoming immunity.
    • Replication-incompetent adenoviral vectors show low-frequency random integration (0.001-1%) into host chromosomes.
    • Hybrid vectors demonstrate potential for improved integration in in vitro systems.

    Conclusions:

    • Adenoviral vectors are promising for gene therapy, but permanent expression requires integration.
    • Hybrid vector systems offer a potential solution for stable gene transduction.
    • Further development of adenoviral and hybrid vectors could lead to more effective in vivo gene therapy strategies.